Clinical Trials Browser

Esophageal Neoplasms

Pancreatic Ductal Adenocarcinoma

Carcinoma, Neuroendocrine

Esophageal Neoplasms, Stomach Neoplasms

Large B-cell Lymphoma

Smoking Cessation, Multiple Pulmonary Nodules

Brain Neoplasms

Adenocarcinoma, Stomach Neoplasms

Hodgkin Disease, Lymphoma

Neuroendocrine Tumors

Prostatic Neoplasms

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Lymphoma, B-Cell, Lymphoma, T-Cell

Ovarian Neoplasms

Neuroendocrine Tumors

Neuroendocrine Tumors

Hepatic Malignancies

Disease, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

Neuroendocrine Tumors

Prostatic Neoplasms

Multiple Myeloma

Breast Cancer Metastases

Prostatic Neoplasms

Breast Neoplasms

Cancer Diagnosis

Prostatic Neoplasms

Nasopharyngeal Carcinoma

Esophageal Neoplasms

Nasopharyngeal Neoplasms

Neuroendocrine Tumors

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Breast Neoplasms

Lymphoma, Non-Hodgkin

Glioblastoma

Pancreatic Neoplasms

Carcinoma, Hepatocellular, Liver Neoplasms

Breast Neoplasms

Prostatic Neoplasms

Lung Neoplasms, Lymphoma, Non-Hodgkin

Pancreatic Neoplasms

Clinical Trials

Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19

CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy

68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)

A Study of PET Scans With the Radioactive Tracer 18F-BMS-986229 in Patients With Esophageal, Stomach, or Gastroesophageal Junction Cancer

89Zr-DFO-REGN3767 in PET Scans in People With Diffuse Large B Cell Lymphoma (DLBCL)

18F-FSPG PET/CT in Diagnosing Early Lung Cancer in Patients With Lung Nodules

A Comparison of MRI Perfusion and FDG PET/CT to Distinguish Between Radiation Injury and Tumor Progression

Heated Intraperitoneal Chemotherapy and Gastrectomy for Gastric Cancer With Positive Peritoneal Cytology

BURGUND

Imaging Properties of PET Radiotracer [18F]3F-PHPG in Patients With Neuroendocrine Tumors

Digital PET/CT Using [Ga-68]PSMA vs. [F-18]NaF for Evaluation of Osseous Metastatic Involvement in Prostate Cancer Patients

Comparing 18F-FAPI-04 and 18F-FDG PET/CT in Cancer Detection

Evaluation of Brain Functional Changes With 18F-FDG PET and Cognitive Processes After Brain Radiotherapy for Cavernous Sinus Meningiomas and Non-secreting ACTH Adenomas

Predictive Role of [11C] Choline PET/CT on Survival in Prostate Cancer Patients With Biochemical Failure.

AIMN Multicenter Study: 18 F-FDG PET-CT With or Without Contrast Medium in the Staging and Radiation of Lung Cancer?

PET/CT Quantitative Assessment of Myocardial Blood Flow Changes in Oncologic Patients Receiving Checkpoint Inhibitor Therapy

ASTRAL- a Clinical Study to Assess the Efficacy and Toxicity of High-dose Chemotherapy

IMAGE

PET/CT Imaging of Angiogenesis in Patients With Neuroendocrine Tumors Using 68Ga-NODAGA-E[c(RGDyK)]2

PET/CT Imaging of uPAR-expression in Patients With Neuroendocrine Tumors Using 68Ga-NOTA-AE105

Comparison of Yttrium-90 Absorbed Doses Using PET/CT Versus PET/MR Imaging for Hepatic Malignancies

PIPPIN

Al18F-NOTA-octreotide PET Imaging in Neuroendocrine Tumors

Gallium-68 PSMA-11 PET Imaging in Prostate Cancer Patients

First-in- Human Imaging of Multiple Myeloma Using 89Zr-DFO-daratumumab, a CD38-targeting Monoclonal Antibody

Can HER2 Targeted PET/CT Imaging Identify Unsuspected HER2 Positive Breast Cancer Metastases, Which Are Amenable to HER2 Targeted Therapy?

68Ga-RM2 for PET/CT of Gastrin Releasing Peptide Receptor (GRPr) Expression in Prostate Cancer

Comparison of MRI With PET / CT in the Evaluation of Response to Neoadjuvant Therapy Based on the Molecular Subtypes of Breast Cancer

Comparison of PET/CT vs. PET/MRI Using 2 Radiopharmaceuticals

PSMA PET

Combining PET/CT and EBV DNA to Evaluate the Hazard of Progression in the Follow-up of Locally Advanced NPC

PRIOR

Assessment of Treatment Response of Nasopharyngeal Cancer Using Simultaneous 18F-FDG-PET and MRI

Al18F-NOTA-octreotide PET Imaging of the Somatostatin Receptor in Neuroendocrine Tumors

PET CT Re-Planning NSCLC (4DCT-PET)

PET/CT or PET/MRI in Measuring Tumors in Patients Undergoing Clinical Imaging or With Newly Diagnosed Breast Cancer

TEP-LYMPHOME

89Zr-J591 Anti-Prostate-Specific Membrane Antigen Monoclonal Antibody in Patients With Glioblastoma Multiforme

Oncologic Outcomes Based on Clinical Pattern of Preoperative PET-CT in Resected Pancreatic Cancer

Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors

uPAR PET/CT for Preoperative Staging of Breast Cancer Patients

Flucipro

IMMETAOS

The Use of Breathing Synchronized CT and PET Scans in Radiation Therapy Treatment Planning

Dynamic PET acquisition-a Quantitative Technique for Grading of Malignant Tumors and Prediction of Response to Treatment